Provided by Tiger Trade Technology Pte. Ltd.

IDEAYA Biosciences

37.59
+0.14000.37%
Post-market: 37.590.00000.00%19:30 EDT
Volume:429.25K
Turnover:16.16M
Market Cap:3.62B
PE:-19.22
High:38.27
Open:37.74
Low:37.24
Close:37.45
52wk High:42.68
52wk Low:24.24
Shares:96.27M
Float Shares:94.37M
Volume Ratio:0.75
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9561
EPS(LYR):-1.2849
ROE:-16.22%
ROA:-11.54%
PB:3.02
PE(LYR):-29.25

Loading ...

IDEAYA files prospectus for up to $156.6 million remaining at-the-market share sales

Reuters
·
May 06

IDEAYA Biosciences Inc Files for Mixed Shelf Offering, Size Not Disclosed- SEC Filing

THOMSON REUTERS
·
May 06

Analysts Are Bullish on Top Healthcare Stocks: Lineage Therap (LCTX), IDEAYA Biosciences (IDYA)

TIPRANKS
·
May 06

Ideaya Biosciences' Darovasertib Combination Data Profile is 'Highly Compelling,' Wedbush Says

MT Newswires Live
·
May 06

IDEAYA Biosciences Q1 EPS $(1.11) Misses $(0.98) Estimate, Sales $6.560M Beat $5.008M Estimate

Benzinga Earnings
·
May 05

IDEAYA Biosciences Q1 net loss widens, misses expectations on higher R&D spends

Reuters
·
May 05

Earnings Flash (IDYA) IDEAYA Biosciences Posts Q1 Loss $1.11 a Share, vs. FactSet Est of $1.05 Loss

MT Newswires Live
·
May 05

IDEAYA Q1 FY26 net loss widens to $98.5 million; revenue falls to $6.6 million

Reuters
·
May 05

IDEAYA Biosciences Inc - Reports ~$973 Mln Cash and Securities as of March 31, 2026; Cash Runway Into 2030 Unchanged

THOMSON REUTERS
·
May 05

IDEAYA Biosciences Inc - to Initiate Rtor Submission in May; Nda Filing Targeted for H2 2026

THOMSON REUTERS
·
May 05

IDEAYA Biosciences Q1 Collaboration Revenue USD 6.56 Million

THOMSON REUTERS
·
May 05

IDEAYA Biosciences Inc - Clinical Updates From Multiple Trials Planned for H2 2026

THOMSON REUTERS
·
May 05

IDEAYA Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
May 05

IDEAYA Biosciences grants inducement stock options for 237,800 shares at $29.1 each

Reuters
·
May 01

IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 01

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Butterfly Network (BFLY), IDEAYA Biosciences (IDYA) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Apr 30

Ideaya Biosciences announces darovasertib combination NDA to be reviewed by FDA

TIPRANKS
·
Apr 30

IDEAYA Biosciences: to Initiate Nda Submission From Darovasertib Optimum-02 Trial

THOMSON REUTERS
·
Apr 30

IDEAYA Biosciences Inc - to Initiate Rtor Submission in May, Nda Filing Completion Expected in H2 2026

THOMSON REUTERS
·
Apr 30

FDA agrees to review IDEAYA darovasertib-crizotinib NDA under RTOR program

Reuters
·
Apr 30